 The study found that CFAM210A, a circular RNA derived from the third exon of transcript NM underscore 001098801 of the FAM210A gene, CIRC base ID, HSA underscore CIRC underscore 003979, can be silenced by HBX and is down-regulated in patients with HBV-related HCC. CFAM210A reduces the proliferation, stenderness, and tumorogenicity of HCC cells by inducing the degradation of CFAM210A via the YTHDF2 HRSP12 RNAs PMRP pathway and inhibiting the phosphorylation of YBX1. These findings suggest that circular RNAs play an important role in HBX-induced hepatocasinogenesis and identify CFAM210A as a potential target for the prevention and treatment of HBV-related HCC. This article was offered by GNU, Wenli, Guojianhu, and others. We are article.tv, links in the description below.